THE European Medicines Agency has urged product sponsors to step up efforts to ensure medicine supply in the European Union in the lead up to the UK's exit from the EU.
The agency has expressed "serious concerns" that regulatory actions to transfer authorisations to European-based entities by UK firms will not be carried out in time.
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Jul 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Jul 18